-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Comprehensive and effective system of standard operating procedures for investigator-initiated trials
Heike Moenkemann, Rita Pilger, Sylvia Reinecker, Peggy Houben & Ursula Paulu
Special Report: Clinical Investigation
-
Comprehensive and effective system of standard operating procedures for investigator-initiated trials
Heike Moenkemann, Rita Pilger, Sylvia Reinecker, Peggy Houben & Ursula Paulu
Special Report: Clinical Investigation
-
Comprehensive and effective system of standard operating procedures for investigator-initiated trials
Heike Moenkemann, Rita Pilger, Sylvia Reinecker, Peggy Houben & Ursula Paulu
Special Report: Clinical Investigation
-
Comprehensive and effective system of standard operating procedures for investigator-initiated trials
Heike Moenkemann, Rita Pilger, Sylvia Reinecker, Peggy Houben & Ursula Paulu
Special Report: Clinical Investigation
-
Comprehensive and effective system of standard operating procedures for investigator-initiated trials
Heike Moenkemann, Rita Pilger, Sylvia Reinecker, Peggy Houben & Ursula Paulu
Special Report: Clinical Investigation
-
Comprehensive and effective system of standard operating procedures for investigator-initiated trials
Heike Moenkemann, Rita Pilger, Sylvia Reinecker, Peggy Houben & Ursula Paulu
Special Report: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Core outcomes in vitiligo trials: progress and challenges
V Eleftheriadou, KS Thomas, JM Batchelor, JC Ravenscroft, ME Whitton
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Ethical issues of placebo-controlled clinical trials in multiple sclerosis
Jeffrey A Cohen
Interview: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
Investigational drug shows significant improvement in cancer survival rate
News and Views: Clinical Investigation
-
How to advance medical research: less regulation, more money and more specific strategies?
OA Cornely, D Arenz
Editorial: Clinical Investigation
-
How to advance medical research: less regulation, more money and more specific strategies?
OA Cornely, D Arenz
Editorial: Clinical Investigation
-
How to advance medical research: less regulation, more money and more specific strategies?
OA Cornely, D Arenz
Editorial: Clinical Investigation
-
How to advance medical research: less regulation, more money and more specific strategies?
OA Cornely, D Arenz
Editorial: Clinical Investigation
-
How to advance medical research: less regulation, more money and more specific strategies?
OA Cornely, D Arenz
Editorial: Clinical Investigation
-
How to advance medical research: less regulation, more money and more specific strategies?
OA Cornely, D Arenz
Editorial: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation
-
New advances in the treatment of Friedreich ataxia: promises and pitfalls
Wolfgang Nachbauer, Sylvia Boesch
Therapeutic Prospective: Clinical Investigation